These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7836509)

  • 61. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.
    Christin-Maitre S; Hugues JN;
    Hum Reprod; 2003 Aug; 18(8):1626-31. PubMed ID: 12871872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation.
    Yu Ng EH; Chi Wai Chan C; Tang OS; Shu Biu Yeung W; Chung Ho P
    Hum Reprod; 2004 Dec; 19(12):2811-5. PubMed ID: 15358718
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone.
    Kamrava MM; Seibel MM; Berger MJ; Thompson I; Taymor ML
    Fertil Steril; 1982 Apr; 37(4):520-3. PubMed ID: 6802679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ["Step protocols"].
    Hugues JN
    Contracept Fertil Sex; 1998 Apr; 26(4):307-11. PubMed ID: 9622966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
    Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone.
    Shoham Z; Patel A; Jacobs HS
    Fertil Steril; 1991 Jun; 55(6):1051-6. PubMed ID: 1903725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
    Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S
    Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome.
    Guido M; Belosi C; Selvaggi L; Lattanzi F; Apa R; Fulghesu AM; Lanzone A
    Gynecol Endocrinol; 2003 Jun; 17(3):215-21. PubMed ID: 12857429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Induction of follicle maturation with "pure" FSH in polycystic ovary syndrome].
    Birkhäuser MH; Huber PR; Neuenschwander E; Näpflin S
    Geburtshilfe Frauenheilkd; 1988 Apr; 48(4):220-7. PubMed ID: 3132413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.
    van Dessel HJ; Schoot BC; Schipper I; Dahl KD; Fauser BC
    Hum Reprod; 1996 Mar; 11(3):478-85. PubMed ID: 8671250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proper selection of patients for intermediate-dose pure follicle stimulating hormone.
    Kim JH; Richards CJ; Seibel MM
    J Reprod Med; 1994 Jan; 39(1):1-5. PubMed ID: 8169907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.
    White DM; Polson DW; Kiddy D; Sagle P; Watson H; Gilling-Smith C; Hamilton-Fairley D; Franks S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3821-4. PubMed ID: 8923819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.